NCT05262933

Brief Summary

The prospective study is planned in a university hospital. Spinal anesthesia is widely used for cesarean section currently for its safety, low cost, reliability, easiness to administer, immediate effect, and well-operating conditions. However spinal anesthesia has some complications as hypotension, bradycardia and Post Dural Puncture Headache (PDPH). A practical strategy for avoiding hypotension during initiation of spinal anesthesia for cesarean delivery includes intravenous crystalloid, in conjunction with administration of vasopressors. PDPH is one of the most frequent complications of spinal anesthesia. Conservative therapies such as bed rest, hydration, and caffeine are commonly used as management. For this study, coffee group of patients will be given unsweetened brewed coffee 150 ml until 2-4 hours before surgery. Patients who accept to drink brewed coffee ( coffee group) and water( control group) will be included in the study. The patient's heart rate, blood pressure, oxygen saturation will be monitored and recorded during operation. Intraoperative will be recorded to amount of vasopressor and intraveous crystalloid. Whether the patient develops PDPH in the postoperative period will be followed for 3 days. In addition abdominal auscultation for bowel sounds hourly and the time of first bowel movements will be recorded. According to the patient's statement, the time of first flatulence and defecation will be followed and recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
13 days until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

February 21, 2022

Last Update Submit

May 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • hypotension

    effects of orally coffee intake on spinal anesthesia induced hypotension

    intraoperative time period

Secondary Outcomes (2)

  • Post-dural puncture headache

    post operative 3 days

  • intestinal motility, first flatus

    post operative 3 days

Study Arms (2)

coffee (n= 70)

Patients are planned to drink brewed coffee 2 hours before surgery.

Other: coffee

control (n=70)

Patients are planned to drink water 2 hours before surgery.

Other: Water

Interventions

coffeeOTHER

It will be given to patients brewed coffee to drink and evaluated to hypotension and post spinal puncture headache

Also known as: It will be given to patients brewed coffee to drink
coffee (n= 70)
WaterOTHER

It will be given to patients water to drink and evaluated to hypotension and post spinal puncture headache

Also known as: It will be given to patients water to drink
control (n=70)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

parturient women aged 18-45

You may qualify if:

  • patients who accept to participate in the study
  • patient who limit the consumption of caffeinated beverages such as coffee and tea during pregnancy
  • Patients with known caffeine or coffee allergy

You may not qualify if:

  • patients who refuse to participate in the study
  • Patients with known cardiovascular disease
  • Patients with known cerebrovascular disease
  • patients with known neurological, neurodegenerative or psychiatric disease
  • patients with known liver failure
  • patient followed up with eclampsia and preaclampsi
  • higher number of needle passes in spinal anesthesia
  • patients treated with an antiemetic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University

Kayseri, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Post-Dural Puncture Headache

Interventions

CoffeeWater

Condition Hierarchy (Ancestors)

Headache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 21, 2022

First Posted

March 2, 2022

Study Start

March 15, 2022

Primary Completion

June 1, 2022

Study Completion

July 1, 2022

Last Updated

May 16, 2024

Record last verified: 2024-05

Locations